Why Amphenol (APH) Could Beat Earnings Estimates Again
When looking at the last two reports, this maker of fiber-optic products has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 15.58%, on average, in the last two quarters.
For the most recent quarter, Amphenol was expected to post earnings of $0.63 per share, but it reported $0.52 per share instead, representing a surprise of 21.15%. For the previous quarter, the consensus estimate was $0.5 per share, while it actually produced $0.55 per share, a surprise of 10.00%.
Price and EPS Surprise
Thanks in part to this history, there has been a favorable change in earnings estimates for Amphenol lately. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the stock is positive, which is a great indicator of an earnings beat, particularly when combined with its solid Zacks Rank.
Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Amphenol currently has an Earnings ESP of +0.32%, which suggests that analysts have recently become bullish on the company's earnings prospects. This positive Earnings ESP when combined with the stock's Zacks Rank #2 (Buy) indicates that another beat is possibly around the corner. We expect the company's next earnings report to be released on July 23, 2025.
Investors should note, however, that a negative Earnings ESP reading is not indicative of an earnings miss, but a negative value does reduce the predictive power of this metric.
Many companies end up beating the consensus EPS estimate, though this is not the only reason why their shares gain. Additionally, some stocks may remain stable even if they end up missing the consensus estimate.
Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Amphenol Corporation (APH) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
Alphabet (GOOGL) Boasts Earnings & Price Momentum: Should You Buy?
Building an investment portfolio from scratch can be difficult, especially if you're new to investing. It's easy to feel overwhelmed with so many different investment options out there, but focusing on stocks that are set to outperform the market over the next 12 months is an excellent place to start. Now, let's take a deep dive into a great stock that could be just the right addition to your portfolio. Why You Should Pay Attention to Alphabet (GOOGL) Alphabet is one of the most innovative companies in the modern technological age. Over the last few years, the company has evolved from primarily a search-engine provider to cloud computing, ad-based video and music streaming, autonomous vehicles, healthcare and others. In the online search arena, Google has a monopoly with more than 94% of the online search volume and market. Over the years, the company has witnessed increase in search queries, resulting from ongoing growth in user adoption and usage, primarily on mobile devices, continued growth in advertiser activity, and improvements in ad formats. GOOGL was added to the Zacks Focus List on May 19, 2025 at $166.19 per share. Since then, shares have increased 18.25% to $196.52. 16 analysts revised their earnings estimate higher in the last 60 days for fiscal 2025, while the Zacks Consensus Estimate has increased $0.41 to $9.94. GOOGL also boasts an average earnings surprise of 16%. Moreover, analysts are expecting Alphabet's earnings to grow 23.6% for the current fiscal year. It can be very profitable to buy stocks with rising earnings estimates, as stock prices respond to revisions. By adding a Focus List stock like GOOGL, there's a great chance you'll be getting into a company whose future earnings estimates will be raised, which can lead to price momentum. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Alphabet Inc. (GOOGL) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Intel Corporation (INTC) is Attracting Investor Attention: Here is What You Should Know
Intel (INTC) has been one of the most searched-for stocks on lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this world's largest chipmaker have returned -17% over the past month versus the Zacks S&P 500 composite's +1.9% change. The Zacks Semiconductor - General industry, to which Intel belongs, has gained 12.2% over this period. Now the key question is: Where could the stock be headed in the near term? While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making. Revisions to Earnings Estimates Rather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings. Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements. Intel is expected to post earnings of $0.01 per share for the current quarter, representing a year-over-year change of +102.2%. Over the last 30 days, the Zacks Consensus Estimate has changed -5.4%. For the current fiscal year, the consensus earnings estimate of $0.15 points to a change of +215.4% from the prior year. Over the last 30 days, this estimate has changed -28.7%. For the next fiscal year, the consensus earnings estimate of $0.68 indicates a change of +353.3% from what Intel is expected to report a year ago. Over the past month, the estimate has changed -5.6%. Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Intel is rated Zacks Rank #3 (Hold). The chart below shows the evolution of the company's forward 12-month consensus EPS estimate: 12 Month EPS Revenue Growth Forecast While earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth. For Intel, the consensus sales estimate for the current quarter of $13.13 billion indicates a year-over-year change of -1.2%. For the current and next fiscal years, $52.07 billion and $54.19 billion estimates indicate -1.9% and +4.1% changes, respectively. Last Reported Results and Surprise History Intel reported revenues of $12.86 billion in the last reported quarter, representing a year-over-year change of +0.2%. EPS of -$0.1 for the same period compares with $0.02 a year ago. Compared to the Zacks Consensus Estimate of $11.87 billion, the reported revenues represent a surprise of +8.36%. The EPS surprise was -1100%. Over the last four quarters, Intel surpassed consensus EPS estimates two times. The company topped consensus revenue estimates each time over this period. Valuation No investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance. Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is. The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued. Intel is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade. Conclusion The facts discussed here and much other information on might help determine whether or not it's worthwhile paying attention to the market buzz about Intel. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intel Corporation (INTC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
SurModics (SRDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended June 2025, SurModics (SRDX) reported revenue of $29.57 million, down 2.6% over the same period last year. EPS came in at $0.06, compared to -$0.27 in the year-ago quarter. The reported revenue represents a surprise of +4.29% over the Zacks Consensus Estimate of $28.35 million. With the consensus EPS estimate being -$0.21, the EPS surprise was +128.57%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance. Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how SurModics performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Product sales: $16.76 million versus the two-analyst average estimate of $15.69 million. The reported number represents a year-over-year change of -4.6%. Revenue- Research, development and other: $3.15 million compared to the $2.37 million average estimate based on two analysts. The reported number represents a change of +35.7% year over year. Revenue- Royalties and license fees: $9.66 million versus $10.2 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -7.7% change. View all Key Company Metrics for SurModics here>>> Shares of SurModics have returned +12.9% over the past month versus the Zacks S&P 500 composite's +1.9% change. The stock currently has a Zacks Rank #5 (Strong Sell), indicating that it could underperform the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Surmodics, Inc. (SRDX) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
